Investment
Features
FeesSafety
Academy
More
Pluang+

SLVP ETF rated Buy for strong silver miner gains; KSLV Hold due to limited upside and income focus.

Analyst Insights
11 Sep 2026
Seeking Alpha
View Source
Neutral
SLVP ETF rated Buy for strong silver miner gains; KSLV Hold due to limited upside and income focus.

Lumen Research rates the iShares MSCI Global Silver and Metals Miners ETF (SLVP) as Buy, citing strong earnings leverage to rising silver prices and robust margins in Q2. In contrast, the Kurv Silver Enhanced Income ETF (KSLV) is rated Hold because its high yield mainly returns capital and has underperformed SLVP in total returns, partly due to option strategies limiting gains. With silver expected to remain in deficit and interest rates posing risks, SLVP's potential for price appreciation is favored over KSLV's income approach for the next 6 to 12 months. This analysis highlights the trade-off between growth potential and income in silver-related ETFs amid market volatility.

More News

Bitcoin price nears liquidation point for $70M long whale at 40x leverage on Hyperliquid.

Bitcoin price nears liquidation point for $70M long whale at 40x leverage on Hyperliquid.

A trader on Hyperliquid opened a massive 40x leveraged long position of 911.55 BTC worth about $70 million at an average price of $77,733. The liquidation price is $76,308.60, and Bitcoin's current price near $77,150 leaves less than 1% room before t...

Market News
Bearish
4 hours ago
Houthis seize Yemen's Mokha port, raising risks to key oil shipping routes and keeping oil prices above $100.

Houthis seize Yemen's Mokha port, raising risks to key oil shipping routes and keeping oil prices above $100.

The Iran-backed Houthi militant group has taken control of Yemen's strategic Red Sea port city of Mokha, near the critical Bab el-Mandeb Strait. This move threatens global shipping lanes and increases pressure on oil supply routes, contributing to oi...

Market News
Bearish
4 hours ago
Class action lawsuit filed against Capricor Therapeutics over misleading FDA approval claims.

Class action lawsuit filed against Capricor Therapeutics over misleading FDA approval claims.

Capricor Therapeutics faces a class action lawsuit alleging it made false statements about the progress of its deramiocel drug candidate toward FDA approval. The lawsuit claims the company misled investors by promoting positive trial results while kn...

Market News
Bearish
4 hours ago
Trainline shares jump 10% on £100m buyback and strong margin update, Shore Capital upgrades to 'buy'.

Trainline shares jump 10% on £100m buyback and strong margin update, Shore Capital upgrades to 'buy'.

Trainline PLC shares rose nearly 10% after announcing a £100 million share buyback and reporting adjusted EBITDA margins slightly above guidance. Group net ticket sales were flat at £3.3 billion, and revenue was down 1%, both better than expected. Sh...

Market News
Bullish
4 hours ago
Raydium token jumps 90% in a week, hitting an 11-month high amid key upgrades and buybacks.

Raydium token jumps 90% in a week, hitting an 11-month high amid key upgrades and buybacks.

Raydium's token (RAY) surged 90% this week to $1.75, its highest price since October 2025, outperforming most cryptocurrencies despite a broader market decline. The rally was driven by three main catalysts: StonkFun moving all new token launches to R...

Protocol Fundamentals
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App